Connect to other sites within the UBM Medica Network
Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Breast Cancer Family History Does Not Mean Poor Prognosis
A new study suggests that a family history of breast cancer does not result in a worse prognosis breast cancer prognosis.
Tailoring Therapy Ups Cure Rates for Children With Rare Kidney Cancer
According to the AREN0532 and AREN0533 trials, adding additional drugs to a therapy regimen for Wilms tumor in children with high-risk disease improved outcomes.
Childhood Cancer Therapies Linked to Adult Obesity
Childhood cancer patients treated with brain irradiation may be at a higher risk for developing into obese adults, according to a new study.
New Paradigm Emerging in Prostate Cancer, Moving Chemo Up the Line
The STAMPEDE trial suggests that survival can be improved in metastatic prostate cancer patients with the addition of docetaxel to frontline hormonal therapy.
Surveillance Compliance Improves Head and Neck Cancer Survival
A new study found that compliance with post-treatment clinical surveillance improved survival outcomes in patients with head and neck squamous cell carcinoma.
Nipple-Sparing Mastectomy as Safe as More Radical Surgeries
A large meta-analysis found that mastectomies that preserve the nipple plus an envelope of breast skin are as safe as surgeries that remove more breast tissue.
Statins Benefit ADT-Treated Prostate Cancer Patients
Disease progression among prostate cancer patients starting androgen deprivation therapy (ADT) was delayed by 10 months in patients already receiving statins.
Metformin May Not Improve Pancreatic Cancer Survival
Metformin, a common drug for type II diabetes, did not improve the survival of patients with pancreatic ductal adenocarcinoma.
Top Highlights From the 2015 AACR Annual Meeting
This slide show features some of the top highlights from the 2015 American Association for Cancer Research (AACR) Annual Meeting.
Benefits of Multi-Gene Panel Testing for Breast Cancer Risk
A multi-gene panel test provides better diagnostic yield compared with a limited BRCA1/2 genetic test for patients at risk for hereditary breast cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.